18 May 2013
Keywords: Quintiles, Dayarn Pharma, Joint venture, MENA markets
Article | 16 February 2012
Biopharmaceutical services company Quintiles is extending its global footprint to provide commercial services in the Middle East and North Africa ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 February 2012
17 May 2013
© 2013 thepharmaletter.com